Growth and Safety of a Low Lactose Milk-Based Infant Formula
NCT ID: NCT01497314
Last Updated: 2013-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2011-12-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Growth and Tolerance of Infants Fed Milk-Based Infant Formula
NCT03967132
Probiotic Formula and Infant Growth
NCT01476397
Growth and Tolerance of Young Infants Fed Infant Formula
NCT04105686
Healthy Term Infants Fed Milk-Based Infant Formula
NCT04529759
Effect of Infant Formula Intake on Infant Growth From 0 to 6 Months.
NCT02997826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Lactose Infant Formula
Low Lactose Infant Formula
Low Lactose Infant Formula
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low Lactose Infant Formula
Low Lactose Infant Formula
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* birth weight 2500 - 4500 g
* singleton birth
* 37 - 42 weeks gestation
Exclusion Criteria
* receiving medications other than vitamins
14 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Perrigo Nutritionals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cynthia M Barber, PhD
Role: STUDY_DIRECTOR
Perrigo Nutritionals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Accelovance Melbourne Site
Melbourne, Florida, United States
ACC Pediatric Research
Haughton, Louisiana, United States
Center for Pharmaceutical Research
Kansas City, Missouri, United States
Research Across America
Dallas, Texas, United States
Jean Brown Research
Murray, Utah, United States
PI-Coor Research
Burke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRG-VA-12-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.